Genotyping Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Genotyping stocks.

Genotyping Stocks Recent News

Date Stock Title
Apr 16 A Agilent Receives Scientists' Choice Awards for Sustainability
Apr 15 LH Laboratory Corporation of America Holdings (NYSE:LH) Has Announced A Dividend Of $0.72
Apr 15 A Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
Apr 15 LH Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Apr 15 ILMN European Commission approves Illumina’s proposed Grail split
Apr 12 ILMN Illumina’s Grail divestment approved by EU (update)
Apr 12 LH Labcorp's (LH) At-Home Mpox Testing Kit Gets the FDA's EUA Nod
Apr 12 ILMN Illumina's planned divestment of GRAIL approved by the European Commission
Apr 12 ILMN UPDATE 2-EU approves Illumina's plan to divest cancer test maker Grail
Apr 12 ILMN EU approves Illumina's plan to divest cancer test maker Grail
Apr 11 LH Myriad Genetics (MYGN) Announces Favorable Research Results
Apr 11 A Waters (WAT) Boosts Waters Operating Segment With HPLC System
Apr 10 LH Labcorp wins FDA emergency use nod for monkeypox test
Apr 10 ILMN Search for Cancer Blood Test Continues Despite Illumina-Grail Deal’s Failure
Apr 10 LH Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit
Apr 10 A Illumina CFO steps down amid executive shakeup
Apr 10 ILMN Illumina CFO steps down amid executive shakeup
Apr 9 ILMN UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
Apr 9 ILMN Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
Apr 9 ILMN Illumina appoints Ankur Dhingra as Chief Financial Officer
Genotyping

Genotyping is the process of determining differences in the genetic make-up (genotype) of an individual by examining the individual's DNA sequence using biological assays and comparing it to another individual's sequence or a reference sequence. It reveals the alleles an individual has inherited from their parents. Traditionally genotyping is the use of DNA sequences to define biological populations by use of molecular tools. It does not usually involve defining the genes of an individual.
Current methods of genotyping include restriction fragment length polymorphism identification (RFLPI) of genomic DNA, random amplified polymorphic detection (RAPD) of genomic DNA, amplified fragment length polymorphism detection (AFLPD), polymerase chain reaction (PCR), DNA sequencing, allele specific oligonucleotide (ASO) probes, and hybridization to DNA microarrays or beads. Genotyping is important in research of genes and gene variants associated with disease. Due to current technological limitations, almost all genotyping is partial. That is, only a small fraction of an individual’s genotype is determined, such as with (epi)GBS (Genotyping by sequencing) or RADseq. New mass-sequencing technologies promise to provide whole-genome genotyping (or whole genome sequencing) in the future.
Genotyping applies to a broad range of individuals, including microorganisms. For example, viruses and bacteria can be genotyped. Genotyping in this context may help in controlling the spreading of pathogens, by tracing the origin of outbreaks. This area is often referred to as molecular epidemiology or forensic microbiology.
Humans can also be genotyped. For example, when testing fatherhood or motherhood, scientists typically only need to examine 10 or 20 genomic regions (like single-nucleotide polymorphism (SNPs)), which represent a tiny fraction of the human genome.
When genotyping transgenic organisms, a single genomic region may be all that needs to be examined to determine the genotype. A single PCR assay is typically enough to genotype a transgenic mouse; the mouse is the mammalian model of choice for much of medical research today.

Browse All Tags